Dimensional Fund Advisors
APRE icon

Dimensional Fund Advisors’s Aprea Therapeutics APRE Stock Holding History

Dimensional Fund Advisors’s Portfolio APRE Stock Details APRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14,465
Closed -$24.6K – 3276
2025
Q2 		$24.6K Sell
14,465
-2,190
-13% -$3.73K ﹤0.01% 3263
2025
Q1 		$34K Sell
16,655
-409
-2% -$1.28K ﹤0.01% 3277
2024
Q4 		$56K Hold
17,064
– – ﹤0.01% 3283
2024
Q3 		$46.9K Buy
17,064
+5,993
+54% +$21.1K ﹤0.01% 3304
2024
Q2 		$45.1K Buy
+11,071
New +$57.1K ﹤0.01% 3323

Other funds holding APRE

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Dimensional Fund Advisors's APRE Position: Q3 2025 in Review

Dimensional Fund Advisors sold out of Aprea Therapeutics (APRE) in Q3 2025, closing a stake of 14,465 shares — an estimated $24.6K sold.

Dimensional Fund Advisors first reported a position in APRE in Q2 2024 and held it in 5 quarters. The position peaked at $56K in Q4 2024. 23 funds tracked by Wall St. Rank hold APRE as of Q3 2025.

  • Dimensional Fund Advisors reported no remaining Aprea Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Dimensional Fund Advisors sold 14,465 Aprea Therapeutics shares in Q3 2025, an estimated $24.6K.
  • Dimensional Fund Advisors first reported a position in Aprea Therapeutics in Q2 2024 and held it in 5 quarters.
  • Dimensional Fund Advisors's Aprea Therapeutics position peaked at $56K in Q4 2024.
  • 23 funds tracked by Wall St. Rank held Aprea Therapeutics as of Q3 2025.

Based on Dimensional Fund Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.